1
|
Sham S, Geetha SD, Kawam A, Bendari A, Al-Refai R, Anjali F, Harshan M, Das K. Malignant Pericardial Effusion from Cervical Squamous Cell Carcinoma: A Case Study. AMERICAN JOURNAL OF CASE REPORTS 2024; 25:e943013. [PMID: 39192560 PMCID: PMC11370198 DOI: 10.12659/ajcr.943013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2024] [Revised: 07/18/2024] [Accepted: 02/08/2024] [Indexed: 08/29/2024]
Abstract
BACKGROUND Cervical cancer ranks fourth globally among women's cancers. Squamous cell carcinoma constitutes 70% of cervical cancer cases, often metastasizing to lungs and paraaortic nodes. Uncommon sites include the brain, skin, spleen, and muscle, while pericardial fluid metastasis is highly rare. We report a case of squamous cell carcinoma of the uterine cervix that was metastatic to the pericardium and was detected on cytologic evaluation of pericardial fluid. CASE REPORT A 42-year-old woman who was previously treated for stage III squamous cell carcinoma of the cervix presented with symptoms of cough, fever, and shortness of breath for 8 days, and chest pain for 3 days. Clinical workup revealed pericardial effusion, with spread to the lungs and mediastinal and hilar lymph nodes. Cytological analysis of the fluid showed malignant cells, consistent with metastatic squamous cell carcinoma. Immunohistochemistry demonstrated cells positive for p63 and p40, while negative for GATA-3, D2-40, calretinin, and WT1. These findings in conjunction with patient's known history of cervical squamous cell carcinoma was consistent with a cytologic diagnosis of metastatic squamous cell carcinoma to pericardial fluid. CONCLUSIONS History and clinical correlation plays a vital role in determining the primary site causing malignant pericardial effusions. While the occurrence of cervical cancer metastasizing to the pericardium is uncommon, it should be considered, particularly in cases involving high-grade, invasive tumors, recurrences, or distant metastases. This possibility should be included in the list of potential diagnoses when encountering pericardial effusions with squamous cells in female patients.
Collapse
Affiliation(s)
- Sunder Sham
- Department of Pathology and Laboratory Medicine, Northwell, Health Lenox Hill Hospital, New York City, NY, USA
| | - Saroja Devi Geetha
- Department of Pathology and Laboratory Medicine, Zucker School of Medicine, North Shore University Hospital/Long Island Jewish Medical Center, Northwell Health, Greenvale, NY, USA
| | - Alae Kawam
- Department of Pathology and Laboratory Medicine, Ameripath/Quest, Indianapolis, IN, USA
| | - Ahmed Bendari
- Department of Pathology and Laboratory Medicine, Northwell, Health Lenox Hill Hospital, New York City, NY, USA
| | - Reham Al-Refai
- Department of Pathology and Laboratory Medicine, Northwell, Health Lenox Hill Hospital, New York City, NY, USA
| | - F.N.U. Anjali
- Department of Pathology and Laboratory Medicine, Sakhi Baba General Hospital, Sindh, Pakistan
| | - Manju Harshan
- Department of Pathology and Laboratory Medicine, Northwell, Health Lenox Hill Hospital, New York City, NY, USA
| | - Kasturi Das
- Department of Pathology and Laboratory Medicine, Zucker School of Medicine, North Shore University Hospital/Long Island Jewish Medical Center, Northwell Health, Greenvale, NY, USA
| |
Collapse
|
2
|
Dakshinamurthy S, Racherla RG, Belagal P, Bharathi T, Sai Gopal DVR. Detection and Partial Molecular Characterization (E6–E7 Region-Early Genes) and Prevalence of Human Papillomavirus (HPV) Causing Cervical Cancer in and Around Tirupati Region, Andhra Pradesh. INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY 2023. [DOI: 10.1007/s40944-022-00702-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/12/2023]
|
3
|
Bobadilla ML, Villagra V, Ortiz V, Deluca G, de Paula VS. High prevalence and co-infection of high-risk Human Papillomavirus genotypes among unvaccinated young women from Paraguay. PLoS One 2023; 18:e0283542. [PMID: 37023094 PMCID: PMC10079089 DOI: 10.1371/journal.pone.0283542] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2022] [Accepted: 03/10/2023] [Indexed: 04/07/2023] Open
Abstract
Paraguay launched a human papillomavirus (HPV) vaccination program in 2013, so virological surveillance is important for measuring the impact of HPV vaccines. This study aimed to estimate the type-specific HPV frequency in unvaccinated sexually active women aged 18-25 years in the metropolitan area of Asuncion as a baseline for monitoring the HPV vaccination program. This study included 208 women, attending the Central Laboratory of Public Health between May 2020 and December 2021, were invited for testing through social networks and flyers at local health centers and higher education institutes. All participants who agreed to contribute to the study signed a free, prior, and informed consent form and answered a questionnaire that included basic demographic data and determining factors of HPV infection. Human papillomavirus detection and genotyping were conducted using the CLART HPV2 test (Genomica, Madrid, Spain) that allows the individual identification of 35 genotypes. 54.8% women were positive for any HPV type, with 42.3% positive for high-risk HPV (HR-HPV) types. Several factors were associated with HPV detection including the number of sexual partners, new sexual partners, non-use of condoms, and history of other sexual infections. Moreover, multiple infections were identified in 43.0% of the young women. We detected 29 different viral types present in both single and multiple infections. HPV-58 was the most commonly detected HPV type (14.9%), followed by HPV-16, HPV-51, and HPV-66 (12.3%). We estimated the prevalence of bivalent (16/18), quadrivalent (6/11/16/18), and nonavalent (6/11/16/18/31/33/45/52/58) vaccine types to be 8.2%, 13%, and 38%, respectively. These results reinforce the importance of surveillance studies and provide the first data regarding circulating HPV genotypes in the unvaccinated population in Paraguay, thus generating a baseline to compare future changes in the overall and type-specific HPV prevalence after HPV vaccination.
Collapse
Affiliation(s)
- María Liz Bobadilla
- Laboratory of Immunology, Central Laboratory of Public Health/Minister of Public Health and Social Welfare, Asunción, Paraguay
- Laboratory of Molecular Virology and Parasitology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
| | - Verónica Villagra
- Laboratory of Immunology, Central Laboratory of Public Health/Minister of Public Health and Social Welfare, Asunción, Paraguay
| | - Violeta Ortiz
- Laboratory of Immunology, Central Laboratory of Public Health/Minister of Public Health and Social Welfare, Asunción, Paraguay
| | - Gerardo Deluca
- Molecular Applications Laboratory, Faculty of Medicine, Northeast National University, Corrientes, Argentina
| | - Vanessa Salete de Paula
- Molecular Applications Laboratory, Faculty of Medicine, Northeast National University, Corrientes, Argentina
| |
Collapse
|
4
|
Zhang Z, Li D, Li Y, Zhang R, Xie X, Yao Y, Zhao L, Tian X, Yang Z, Wang S, Yue X, Mei X. The correlation between Trichomonas vaginalis infection and reproductive system cancer: a systematic review and meta-analysis. Infect Agent Cancer 2023; 18:15. [PMID: 36864428 PMCID: PMC9979407 DOI: 10.1186/s13027-023-00490-2] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2022] [Accepted: 02/14/2023] [Indexed: 03/04/2023] Open
Abstract
BACKGROUND Trichomonas vaginalis (T. vaginalis) is a microaerophilic protozoan parasite which is responsible for trichomoniasis, the most common non-viral sexually transmitted infection in the world. The infection greatly damages the reproductive system. However, whether T. vaginalis infection can cause reproductive system cancer remains controversial. METHODS This study systematically searched PubMed, EMBASE, Ovid and Google scholar, and 144 relevant articles were retrieved and classified into three categories: epidemiological investigations (68), reviews (30) and research articles (46). These three types of articles were verified according to their respective inclusion and exclusion criteria. Stata 16 was used to conduct a meta-analysis on the articles of epidemiological investigations for analysing the correlation between T. vaginalis infection and reproductive system cancer. RESULTS The result of meta-analysis indicated that the rate of T. vaginalis infection in the cancer group was significantly higher than that in the non-cancer group (OR = 1.87, 95% CI 1.29-2.71, I2 = 52%). Moreover, the cancer rate of the population infected with T. vaginalis was significantly higher than that of the population without T. vaginalis infection (OR = 2.77, 95% CI 2.37-3.25, I2 = 31%). The review articles and most research articles stated that the infection of T. vaginalis could lead to cancer and the pathogenic mechanisms were as follows: T. vaginalis promoting inflammatory response, T. vaginalis infection changing the internal environment around parasitic sites and signal transduction pathway, the metabolites secreted by T. vaginalis inducing carcinogenesis and T. vaginalis increasing other pathogenic microbial infection to promote the occurrence of cancer. CONCLUSIONS Our study confirmed that there was a correlation between the infection of T. vaginalis and reproductive system cancer, and provided some possible research directions for clarifying the carcinogenic mechanisms caused by T. vaginalis infection.
Collapse
Affiliation(s)
- Zhenchao Zhang
- grid.412990.70000 0004 1808 322XDepartment of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China ,grid.412990.70000 0004 1808 322XXinxiang Key Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China
| | - Dongxian Li
- grid.412990.70000 0004 1808 322XDepartment of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China ,grid.412990.70000 0004 1808 322XXinxiang Key Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China
| | - Yuhua Li
- grid.412990.70000 0004 1808 322XXinxiang Key Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China
| | - Rui Zhang
- grid.412990.70000 0004 1808 322XDepartment of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China ,grid.412990.70000 0004 1808 322XXinxiang Key Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China
| | - Xianghuan Xie
- grid.412990.70000 0004 1808 322XDepartment of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China ,grid.412990.70000 0004 1808 322XXinxiang Key Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China
| | - Yi Yao
- grid.412990.70000 0004 1808 322XDepartment of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China ,grid.412990.70000 0004 1808 322XXinxiang Key Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China
| | - Linfei Zhao
- grid.412990.70000 0004 1808 322XDepartment of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China ,grid.412990.70000 0004 1808 322XXinxiang Key Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China
| | - Xiaowei Tian
- grid.412990.70000 0004 1808 322XDepartment of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China ,grid.412990.70000 0004 1808 322XXinxiang Key Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China
| | - Zhenke Yang
- grid.412990.70000 0004 1808 322XDepartment of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China ,grid.412990.70000 0004 1808 322XXinxiang Key Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China
| | - Shuai Wang
- grid.412990.70000 0004 1808 322XDepartment of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China ,grid.412990.70000 0004 1808 322XXinxiang Key Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China
| | - Xuejing Yue
- grid.412990.70000 0004 1808 322XXinxiang Key Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan 453003 People’s Republic of China
| | - Xuefang Mei
- Department of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, 453003, People's Republic of China. .,Xinxiang Key Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, 453003, People's Republic of China.
| |
Collapse
|
5
|
Fu J, Zhang H. Meta-analysis of the correlation between vaginal microenvironment and HPV infection. Am J Transl Res 2023; 15:630-640. [PMID: 36915746 PMCID: PMC10006789] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2022] [Accepted: 01/19/2023] [Indexed: 03/16/2023]
Abstract
PURPOSE To study the correlation between the vaginal microenvironment and human papillomavirus (HPV) infection by meta-analysis. METHODS Databases including the Chinese Journal Full-text Database, China Science and Technology Journal, Wanfang, PubMed, Embase, Cochrane, and Web of Science were used to comprehensively retrieve published clinical studies on the correlation between the vaginal microenvironment and HPV infection. The retrieval was performed according to the inclusion and exclusion criteria, then qualified clinical studies were included for quality evaluation and data extraction. Revman 5.3 software was used for meta-analysis. The correlation between the vaginal microenvironment and HPV infection was assessed. The statistical results were shown by forest plots. Publication bias was tested by funnel plot. RESULTS Ten independent studies were included in this study, involving 11,649 patients. The meta-analysis results showed that compared with the HPV-negative group, the HPV-positive group had a significant increase in the aerobic vaginitis (OR = 1.73, 95% CI: 1.19-2.50, P = 0.004), bacterial vaginosis (OR = 2.52, 95% CI: 1.78-3.57, P < 0.001) and trichomonal vaginitis (OR = 1.60, 95% CI: 1.27-2.02, P < 0.001) infection rates, while there was no substantial difference in the vulvovaginal candidiasis infection rate between two groups (OR = 1.48, 95% CI: 0.99-2.23, P = 0.06). CONCLUSION The vaginal microenvironment is closely related to HPV infection, especially aerobic vaginitis, bacterial vaginosis and trichomonal vaginitis are high-risk factors for HPV infection.
Collapse
Affiliation(s)
- Jie Fu
- Department of Gynaecology, Lianyungang Hospital of Traditional Chinese Medicine Lianyungang 222003, Jiangsu, China
| | - Hong Zhang
- Department of Gynaecology, Lianyungang Hospital of Traditional Chinese Medicine Lianyungang 222003, Jiangsu, China
| |
Collapse
|
6
|
Bortolli APR, Treco IC, Vieira VK, Pascotto CR, Ferreto LED, Wendt GW, Lucio LC. Prevalence of HPV and associated factors in a population of women living in southern Brazil. Braz J Microbiol 2022; 53:1979-1986. [PMID: 36261773 PMCID: PMC9679043 DOI: 10.1007/s42770-022-00849-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Accepted: 10/12/2022] [Indexed: 01/13/2023] Open
Abstract
OBJECTIVE To determine the prevalence of HPV and investigate factors associated with the infection in women in the city of Francisco Beltrão, southwest Paraná, attending the public health system. METHODS This cross-sectional study included 324 women, aged between 18 and 65 years, who were attending public health services for routine gynecological consultation. Interviews were conducted to obtain information about socioeconomic, sexual, gynecological, and life habits. After performing the Papanicolaou test, endocervical brush was employed to detect HPV by polymerase chain reaction with the primers MY09-MY11. RESULTS The prevalence of HPV was 6.8%, out of which 58.3% presented with cytopathologic alterations. And the presence of current cervical alterations can increase the chances of having HPV by almost 33 times (ORadj: 32.688; p < 0.001), recent vaginal infection increased the chances of HPV infection by 2.7 times (ORadj: 2.773; p = 0.04). The non-white ethnicity increased HPV infection chances threefold (ORadj: 3.058; p = 0.039). CONCLUSION The main finding was low prevalence of HPV infection. Factors that may be linked to HPV infection were cervical alterations, recent vaginal infection, and women's ethnicity.
Collapse
Affiliation(s)
- Ana Paula Reolon Bortolli
- Universidade Estadual Do Oeste Do Paraná, Programa de Pós-Graduação Em Ciências Aplicadas À Saúde, Francisco Beltrão, Paraná, Brazil
| | - Indianara Carlotto Treco
- Universidade Estadual Do Oeste Do Paraná, Programa de Pós-Graduação Em Ciências Aplicadas À Saúde, Francisco Beltrão, Paraná, Brazil
| | - Valquíria Kulig Vieira
- Universidade Estadual Do Oeste Do Paraná, Programa de Pós-Graduação Em Ciências Aplicadas À Saúde, Francisco Beltrão, Paraná, Brazil
| | - Claudicéia Risso Pascotto
- Universidade Estadual Do Oeste Do Paraná, Programa de Pós-Graduação Em Ciências Aplicadas À Saúde, Francisco Beltrão, Paraná, Brazil
| | - Lirane Elize Defante Ferreto
- Universidade Estadual Do Oeste Do Paraná, Programa de Pós-Graduação Em Ciências Aplicadas À Saúde, Francisco Beltrão, Paraná, Brazil
| | - Guilherme Welter Wendt
- Universidade Estadual Do Oeste Do Paraná, Centro de Ciências da Saúde, Francisco Beltrão, Paraná, Brazil
| | - Léia Carolina Lucio
- Universidade Estadual Do Oeste Do Paraná, Programa de Pós-Graduação Em Ciências Aplicadas À Saúde, Francisco Beltrão, Paraná, Brazil.
| |
Collapse
|
7
|
Temesgen MM, Alemu T, Shiferaw B, Legesse S, Zeru T, Haile M, Gelanew T. Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia. PLoS One 2021; 16:e0248949. [PMID: 33760866 PMCID: PMC7990306 DOI: 10.1371/journal.pone.0248949] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2020] [Accepted: 03/08/2021] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND Human papillomavirus (HPV) infection is considered as the major risk factor for the development of cervical cancer, second most frequent cancer in Ethiopia. However, the magnitude of the problem and the associated factors remain unrevealed in the Amhara region. This study aimed to determine the prevalence of HPV infection and factors contributing to the progression of HPV infection to cervical cancer. METHODS Facility-based cross-sectional study design was employed among women aged 21 to 49 years of age who came for routine cervical cancer screening to 4 randomly selected hospitals (2 general and 2 referral) of Amhara region from May to October, 2019. The sample size was calculated by using the single population proportion formula, proportionated to hospitals, and women were recruited consecutively. Socio demographic and clinical data were collected using a pretested questionnaire and detection of HPV infection was done using HPV test (OncoE6TM Cervical Test) specific to HPV16/18 in cervical swabs. Visual inspection with acetic acid (VIA) was used to determine cervical lesions (precancerous and cancerous). Descriptive statistics and bivariate and multivariate logistic regression were used to describe HR-HPV and cervical lesions burden and association between HR-HPV, and cervical lesions and potential risk factors. RESULTS Among 337 women 21 to 49 years (median age of 35 years ±SD = 7.1 years) of age enrolled in the study, The overall prevalence of oncogenic HPVs (HPV16/18) and the VIA-positivity rate, possible an indicative of cervical lesions, were 7.1% and 13.1%, respectively. Logistic regression analysis showed a significant association between early age of first sexual intercourse (COR = 2.26; 95% CI: 1.0-5.05) and level of education (COR = 0.31; 95% CI: 0.12-0.78) with cervical lesions. Higher odds of HPV positivity (COR = 1.56; 95% CI: 0.59-4.11, p = 0.36) and VIA positivity (COR = 1.39; 95% CI: 0.64-3.00, p = 0.39) were observed among participants who had a history of sexually transmitted illnesses (STIs). CONCLUSIONS There was a relatively low prevalence of oncogenic HPV 16/18 and VIA-positivity in women attending four hospitals in the Amhara Region. Early age sexual contact, high parity, and being uneducated/low level of education were independently associated factors with HR-HPV infection and development of cervical lesions, highlighting the importance of prioritizing the limited HPV testing to those risk groups.
Collapse
Affiliation(s)
| | - Tefera Alemu
- Amhara Public Health Institute Dessie Branch, Dessie, Ethiopia
| | | | - Seid Legesse
- Amhara Public Health Institute Dessie Branch, Dessie, Ethiopia
| | - Taye Zeru
- Amhara Public Health Institute, Bahir Dar, Ethiopia
| | | | | |
Collapse
|
8
|
Zhang F, Dai J, Chen T. Role of Lactobacillus in Female Infertility Via Modulating Sperm Agglutination and Immobilization. Front Cell Infect Microbiol 2021; 10:620529. [PMID: 33569356 PMCID: PMC7868545 DOI: 10.3389/fcimb.2020.620529] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2020] [Accepted: 12/08/2020] [Indexed: 12/13/2022] Open
Abstract
Infertility has become a common problem in recent decades. The pathogenesis of infertility is variable, but microbiological factors account for a large proportion of it. Dysbiosis of vaginal microbiota is reportedly associated with female infertility, but the influence of normal vaginal microbiota on infertility is unclear. In this review, we summarize the physiological characteristics of the vaginal tract and vaginal microbiota communities. We mainly focus on the bacterial adherence of vaginal Lactobacillus species. Given that the adherent effect plays a crucial role in the colonization of bacteria, we hypothesize that the adherent effect of vaginal Lactobacillus may also influence the fertility of the host. We also analyze the agglutination and immobilization effects of other bacteria, especially Escherichia coli, on ejaculated spermatozoa, and speculate on the possible effects of normal vaginal microbiota on female fertility.
Collapse
Affiliation(s)
- Fenghao Zhang
- Institute of Translational Medicine & School of Life Sciences, Nanchang University, Nanchang, China
| | - Jie Dai
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China
| | - Tingtao Chen
- Institute of Translational Medicine & School of Life Sciences, Nanchang University, Nanchang, China
| |
Collapse
|
9
|
Moharreri M, Sohrabi A. Characteristics of HSV-2, M. genitalium and C. trachomatis in HPV Genotypes Associated with Cervical Intraepithelial Neoplasia and Genital Infections. Infect Disord Drug Targets 2020; 21:112-118. [PMID: 31889502 DOI: 10.2174/1871526520666191231142317] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2019] [Revised: 11/22/2019] [Accepted: 12/13/2019] [Indexed: 01/09/2023]
Abstract
BACKGROUND Cervical cancer is the most common cancer in women. High-Risk HPV types are known as the main agents involved in genital and cervical malignancies. There may be co pathogens like STIs that are involved in enhancing the susceptibility and progression to cervical neoplasia. This study was conducted to detect C. trachomatis, HSV-2 and M. genitalium using qPCR in women suffering from cervical intraepithelial neoplasia, HPV infection and non cancerous- non HPV subjects for the association of burden of genital disorders. MATERIALS AND METHODS This descriptive study was performed on 195 Liquid Based Cytology (LBCs) specimens collected from women referred to private laboratories. Fifty, 98 and 47 samples were from women with known CIN, HPV positive and non-cancerous/non-HPV, respectively. HSV-2, C. trachomatis, M. genitalium and HPV genotypes have been detected using multiplex TaqMan Real Time PCR and PCR hybridization. RESULTS A total of 148 HPV positive samples were included. HPVs 6 (35.13%), 16 (32.43%), 18 (21.62%), 11 (9.46%), 31 (9.46%), and 51 (9.46%) were the most common genotypes. Single, 2, 3, and more than 4 multiple HPV genotypes were detected in 46%, 29.7%, 14.2%, 10.1% cases, respectively. The prevalence of M. genitalium, C. trachomatis and HSV2 was 3 (1.54%), 24 (12.3%) and 1(0.5%), respectively. There were no statistically significant differences between these pathogens and cervical intraepithelial neoplasia (p≥ 0.05). CONCLUSION HR-HPV genotypes were more prevalent in genital infections and cervical cancer. It would seem early detection of dominant STI pathogens such as Chlamydia spp. gains due to effective prevention. Here, further research is needed to understand the co-infections burden of HPV genotypes with STIs in clinical manifestations.
Collapse
Affiliation(s)
- Mona Moharreri
- Department of Biology, East Tehran Branch, Islamic Azad University, Tehran, Iran
| | - Amir Sohrabi
- Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
| |
Collapse
|
10
|
Ma QF, Guo YL, Gao H, Yan B, Dai X, Xu M, Xiong YJ, Peng QZ, Wang Y, Zou M, Wu XF. Prevalence and Determinants of High-risk HPV Infection among 11549 Women from an Opportunistic Screening in Hubei Province. Curr Med Sci 2019; 39:622-630. [PMID: 31347000 DOI: 10.1007/s11596-019-2083-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2018] [Revised: 04/19/2019] [Indexed: 11/24/2022]
Abstract
High-risk human papillomavirus (hrHPV) infection plays an important role in the development of cervical intraepithelial neoplasia and cervical cancer. A total of 11 549 women were enrolled from the Maternal and Child Health Hospital of Hubei Province. Each participant accepted hrHPV testing and completed a self-administered questionnaire about basic information and potential risk factors. The univariable and multivariable logistic regression model was used to explore the associations between variants and hrHPV infection. Our results showed that hrHPV prevalence was 16.09% in Hubei Province, among which, hrHPV was more likely to be positive in women aged 51 years or above (OR=1.65, 95% CI: 1.28-2.14), and in women who had symptoms of bleeding after intercourse (OR=1.32, 95% CI:1.17-1.50), had first sexual intercourse at the age of 18 years or below (OR=1.33, 95% CI:1.07-1.64), had at least three male sexual partners (OR=2.50, 95% CI:2.07-3.03), and who had been diagnosed with sexually transmitted infections (OR=1.50, 95% CI:1.12-2.03). Married women (OR=0.66, 95% CI: 0.55-0.78) and women who frequently used condoms (OR=0.75, 95% CI:0.67-0.84) had a relatively lower hrHPV prevalence. This study confirms that hrHPV infection was associated with age, marital status, symptoms of intercourse bleeding, history of sexually transmitted infections, and sex-related behaviors. Above all, this study provides a baseline database prior to obtaining vaccinations for dynamic tracking of the changes in hrHPV prevalence.
Collapse
Affiliation(s)
- Quan-Fu Ma
- Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, China.,Cervical Cancer Control Center of Hubei Province, Wuhan, 430070, China
| | - Yu-Lin Guo
- Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, China.,Cervical Cancer Control Center of Hubei Province, Wuhan, 430070, China
| | - Han Gao
- Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, China.,Cervical Cancer Control Center of Hubei Province, Wuhan, 430070, China
| | - Bin Yan
- Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, China.,Cervical Cancer Control Center of Hubei Province, Wuhan, 430070, China
| | - Xuan Dai
- Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, China.,Cervical Cancer Control Center of Hubei Province, Wuhan, 430070, China
| | - Meng Xu
- Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, China.,Cervical Cancer Control Center of Hubei Province, Wuhan, 430070, China
| | - Yu-Jing Xiong
- Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, China
| | - Qiu-Zi Peng
- Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, China
| | - Ying Wang
- Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, China.,Cervical Cancer Control Center of Hubei Province, Wuhan, 430070, China
| | - Miao Zou
- Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, China.,Cervical Cancer Control Center of Hubei Province, Wuhan, 430070, China
| | - Xu-Feng Wu
- Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, China. .,Cervical Cancer Control Center of Hubei Province, Wuhan, 430070, China.
| |
Collapse
|
11
|
Campos-Romero A, Anderson KS, Longatto-Filho A, Luna-Ruiz Esparza MA, Morán-Portela DJ, Castro-Menéndez JA, Moreno-Camacho JL, Calva-Espinosa DY, Acosta-Alfaro MA, Meynard-Mejía FA, Muñoz-Gaitán M, Alcántar-Fernández J. The burden of 14 hr-HPV genotypes in women attending routine cervical cancer screening in 20 states of Mexico: a cross-sectional study. Sci Rep 2019; 9:10094. [PMID: 31300693 PMCID: PMC6626130 DOI: 10.1038/s41598-019-46543-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2019] [Accepted: 07/01/2019] [Indexed: 11/23/2022] Open
Abstract
In Mexico, HPV vaccines available immunize against genotypes 16/18 and 16/18/6/11; however, there is limited surveillance about carcinogenic subtypes in different states of the country that allow evaluating the effectiveness of vaccination and cervical cancer screening programs. Here, we report the regional and age-specific prevalence of 14 hr-HPV genotypes as well as their prevalence in abnormal cytology (from ASCUS to cervical cancer) among Mexican women which were undergoing from cervical cancer screening in the Salud Digna clinics in 20 states of the country. This study includes women with social security from the majority of public health institutions (IMSS, ISSSTE, SEMAR, and PEMEX), and women without social security. For cervical cancer screening, we used the SurePath liquid-based cytology and the BD Onclarity HPV Assay. From December 1, 2016, to August 2, 2018, the hr-HPV prevalence among 60,135 women was 24.78%, the most prevalent types were HPV 16 (4.13%), HPV 31 (4.12%) and HPV 51 (3.39%), while HPV 18 (1.70%) was less prevalent among infected women. Interestingly, the genotypes not covered by current vaccines in Mexico were commonly found in precancerous lesions, evidencing their carcinogenic potential, so it is necessary to increase their surveillance and inclusion in cervical cancer screening triage.
Collapse
Affiliation(s)
| | - Karen S Anderson
- Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, 85287, USA
- School of Life Sciences, Arizona State University, Tempe, AZ, 85287, USA
| | - Adhemar Longatto-Filho
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil
- Life and Health Sciences Research Institute, ICVS, School of Medicine, Minho University, Braga, Portugal
- ICVS/3B's - PT Government Associate Laboratory, Braga, Guimarães, Portugal
- Department of Pathology, LIM14, School of Medicine, University of São Paulo, São Paulo, Brazil
| | | | - David J Morán-Portela
- National Reference Center, Salud Digna, 80300, Culiacan, Sinaloa, Mexico
- Clinical Laboratory Department, Salud Digna, Culiacan, 80000, Sinaloa, Mexico
| | - Javier A Castro-Menéndez
- National Reference Center, Salud Digna, 80300, Culiacan, Sinaloa, Mexico
- Clinical Laboratory Department, Salud Digna, Culiacan, 80000, Sinaloa, Mexico
| | - José L Moreno-Camacho
- National Reference Center, Salud Digna, 80300, Culiacan, Sinaloa, Mexico
- Clinical Laboratory Department, Salud Digna, Culiacan, 80000, Sinaloa, Mexico
| | | | | | - Freddy A Meynard-Mejía
- Medical Sciences Faculty, Universidad Nacional Autonoma de Nicaragua, Managua, Nicaragua
| | - Marlene Muñoz-Gaitán
- Medical Sciences Faculty, Universidad Nacional Autonoma de Nicaragua, Managua, Nicaragua
| | | |
Collapse
|
12
|
Yu Q, Liu Q, Gao Y, Gong H, Tan X, Zhang M, Tuo J, Zhang Y, Xiang Q, Deng F, Liu G. Human papillomavirus type 18/16 infection and prevalence among middle-aged and older Chinese rural women: a cross-sectional survey in Wufeng, Hubei Province. Women Health 2019; 59:1105-1117. [PMID: 30917772 DOI: 10.1080/03630242.2019.1590493] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Qiuli Yu
- School of Health Sciences, Wuhan University, Wuhan, Hubei, China
| | - Qing Liu
- School of Health Sciences, Wuhan University, Wuhan, Hubei, China
| | - Yanduo Gao
- School of Health Sciences, Wuhan University, Wuhan, Hubei, China
| | - Huiyun Gong
- School of Health Sciences, Wuhan University, Wuhan, Hubei, China
| | - Xiaodong Tan
- School of Health Sciences, Wuhan University, Wuhan, Hubei, China
| | - Min Zhang
- Institute of Cancer prevention and Control, Hubei Cancer Hospital, Wuhan, Hubei, China
| | - Jiyu Tuo
- Institute of Cancer prevention and Control, Hubei Cancer Hospital, Wuhan, Hubei, China
| | - Yuling Zhang
- Institute of Cancer prevention and Control, Hubei Cancer Hospital, Wuhan, Hubei, China
| | - Qunying Xiang
- President's Office, Maternal and Child Health Care Hospital, Wufeng, Hubei, China
| | - Fenghua Deng
- President's Office, Maternal and Child Health Care Hospital, Wufeng, Hubei, China
| | - Guiling Liu
- President's Office, Maternal and Child Health Care Hospital, Wufeng, Hubei, China
| |
Collapse
|
13
|
Abstract
Humans and other mammals are colonized by microbial agents across the kingdom which can represent a unique microbiome pattern. Dysbiosis of the microbiome has been associated with pathology including cancer. We have identified a microbiome signature unique to ovarian cancers, one of the most lethal malignancies of the female reproductive system, primarily because of its asymptomatic nature during the early stages in development. We screened ovarian cancer samples along with matched, and non-matched control samples using our pan-pathogen array (PathoChip), combined with capture-next generation sequencing. The results show a distinct group of viral, bacterial, fungal and parasitic signatures of high significance in ovarian cases. Further analysis shows specific viral integration sites within the host genome of tumor samples, which may contribute to the carcinogenic process. The ovarian cancer microbiome signature provides insights for the development of targeted therapeutics against ovarian cancers.
Collapse
|
14
|
Del Río-Ospina L, Soto-De León SC, Camargo M, Sánchez R, Mancilla CL, Patarroyo ME, Patarroyo MA. The Prevalence of High-Risk HPV Types and Factors Determining Infection in Female Colombian Adolescents. PLoS One 2016; 11:e0166502. [PMID: 27846258 PMCID: PMC5112891 DOI: 10.1371/journal.pone.0166502] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2016] [Accepted: 10/18/2016] [Indexed: 01/25/2023] Open
Abstract
This study reports six HR-HPV types’ infection prevalence discriminated by species and multiple infection in unvaccinated Colombian female adolescents, as well as some factors modulating the risk of infection. HPV DNA for six high-risk viral types was identified in cervical samples taken from 2,134 12–19 year-old females using conventional generic and type-specific PCR. Binomial logistical regression analysis was used for modelling HR-HPV infection and multiple infection risk. The interaction between variables in a stepwise model was also included in such analysis. Viral DNA was detected in 48.97% of the females; 28.52% of them had multiple infections, HPV-16 being the most frequently occurring type (37.44%). Cytological abnormality prevalence was 15.61%. Being over 16 years-old (1.66: 1.01–2.71 95%CI), white ethnicity (4.40: 1.16–16.73 95%CI), having had 3 or more sexual partners (1.77: 1.11–2.81 95%CI) and prior sexually-transmitted infections (STI) (1.65: 1.17–2.32 95%CI) were associated with a greater risk of HPV infection. Having given birth was related to a higher risk of infection by A7 species and antecedent of abortion to less risk of coinfection. Where the females in this study came from also influenced the risk of infection by A7 species as female adolescents from the Andean region had a lower risk of infection (0.42: 0.18–0.99 95%CI). The presence of factors related to risky sexual behaviour in the study population indicated that public health services should pay special attention to female adolescents to modify the risk of infection by high-risk HPV types and decrease their impact on this age group.
Collapse
Affiliation(s)
- Luisa Del Río-Ospina
- Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá D.C., Colombia
- School of Medicine, Universidad Nacional de Colombia, Bogotá D.C., Colombia
| | - Sara Cecilia Soto-De León
- Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá D.C., Colombia
- Universidad de Ciencias Aplicadas y Ambientales (UDCA), Bogotá D.C., Colombia
| | - Milena Camargo
- Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá D.C., Colombia
- PhD Programme in Biomedical and Biological Sciences, Universidad del Rosario, Bogotá D.C., Colombia
| | - Ricardo Sánchez
- Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá D.C., Colombia
- School of Medicine, Universidad Nacional de Colombia, Bogotá D.C., Colombia
| | - Cindy Lizeth Mancilla
- Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá D.C., Colombia
| | - Manuel Elkin Patarroyo
- Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá D.C., Colombia
- School of Medicine, Universidad Nacional de Colombia, Bogotá D.C., Colombia
| | - Manuel Alfonso Patarroyo
- Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá D.C., Colombia
- School of Medicine and Health Sciences, Universidad del Rosario, Bogotá D.C., Colombia
- * E-mail:
| |
Collapse
|